Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma have?
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has 203 citations in the OpenAlex counts PICO Portal stores.
When was Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma published?
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has 2015 year in the PICO Portal index.
What is the open-access status of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has green oa status in the PICO Portal index.
What is the DOI of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?
The DOI for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.
What is the PMID of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?
The PMID for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.
What is the OpenAlex record for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?
The OpenAlex for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.